Hunan HuaTeng Pharmaceutical Co., Ltd.

About:

Huateng Pharma offers high-end biological high-tech enterprise certification, chemical reagents & APIs.

Website: https://us.huatengsci.com/

Twitter/X: intermediatePEG

Top Investors: CITIC Securities, Hunan Xingxiang Investment, Shenghong Fund, Boyi Fund, Zhudan Equity Investment Fund

Description:

Hunan Huateng Pharmaceutical Co., Ltd is a company committed to research and development, production and sales of high-end PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents. Huateng pharmaceuticals in Chinese, European and American countries have our own R & D and logistics center, the company has an excellent and efficient R & D and production and sales of a professional team. Fast for all global customers to provide professional, personalized and technical support of the one-stop service, can rapid and efficient delivery of products to the customers all around the world.

Total Funding Amount:

167M CNY

Headquarters Location:

Changshan, Hunan, China

Founded Date:

2013-08-01

Contact Email:

sales(AT)huatengusa.com

Founders:

Zeping Deng

Number of Employees:

251-500

Last Funding Date:

2021-12-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai